News Sentiment

LYEL sentiment intelligence

Lyell Immunopharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 15.01 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+6.8% over one week, +11.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Form S-3 Lyell Immunopharma Inc For: 13 July By Investing.com

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 6.8% Price confirming higher
Trend fit Trend inactive 11.2% over four weeks
Fair value -42.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 36
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
Market source 9
Investing.com 4
TradingView 4
GlobeNewswire 4
simplywall.st 3
MT Newswires 2
Investing.com South Africa 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 13
Analyst action 3
Deals and strategy 3
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54